Diabetes Alters KIF1A and KIF5B Motor Proteins in the Hippocampus

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Baptista, Filipa I ^a   Pinto, Maria J ^b   Elvas, Filipe ^a   Almeida, Ramiro D ^b   Ambrósio, António F ^a,b,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE AIBILI   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DYNEIN ADENOSINE TRIPHOSPHATASE; GLUCOSE; MANNITOL; MESSENGER RNA; MITOCHONDRIAL PROTEIN; MOLECULAR MOTOR; PROTEIN KIF1A; PROTEIN KIF5B; STREPTOZOCIN; SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN SLICE; CONTROLLED STUDY; DISEASE DURATION; EMBRYO; HIPPOCAMPUS; HYPERGLYCEMIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MITOCHONDRION; NERVE FIBER TRANSPORT; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES;

ANALYSIS OF VARIANCE; ANIMALS; AXONAL TRANSPORT; BLOTTING, WESTERN; BRAIN DISEASES, METABOLIC; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DNA PRIMERS; DYNEINS; FLUORESCENT ANTIBODY TECHNIQUE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KINESIN; MALE; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 84878951512     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065515     Document Type: Article

References (54)

1. Grillo CA, Piroli GG, Wood GE, Reznikov LR, McEwen BS, et al. (2005) Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience 136: 477-486.
2. Gaspar JM, Baptista FI, Galvao J, Castilho AF, Cunha RA, et al. (2010a) Diabetes differentially affects the content of exocytotic proteins in hippocampal and retinal nerve terminals. Neuroscience 169: 1589-1600.
3. Biessels GJ, Kamal A, Ramakers GM, Urban IJ, Spruijt BM, et al. (1996) Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 45: 1259-1266.
4. Kamal A, Biessels GJ, Urban IJ, Gispen WH, (1999) Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience 90: 737-745.
5. Baptista FI, Gaspar JM, Cristovao A, Santos PF, Kofalvi A, et al. (2011) Diabetes induces early transient changes in the content of vesicular transporters and no major effects in neurotransmitter release in hippocampus and retina. Brain Res 1383: 257-269.
6. Gaspar JM, Castilho A, Baptista FI, Liberal J, Ambrosio AF, (2010b) Long-term exposure to high glucose induces changes in the content and distribution of some exocytotic proteins in cultured hippocampal neurons. Neuroscience 171: 981-992.
7. De Vos KJ, Grierson AJ, Ackerley S, Miller CC, (2008) Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 31: 151-173.
8. Lee PG, Hohman TC, Cai F, Regalia J, Helke CJ, (2001) Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve. Exp Neurol 170: 149-161.
9. Lee PG, Cai F, Helke CJ, (2002) Streptozotocin-induced diabetes reduces retrograde axonal transport in the afferent and efferent vagus nerve. Brain Res 941: 127-136.
10. Jakobsen J, Brimijoin S, Skau K, Sidenius P, Wells D, (1981) Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats. Diabetes 30: 797-803.
11. Medori R, Autilio-Gambetti L, Monaco S, Gambetti P, (1985) Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional area. Proc Natl Acad Sci U S A 82: 7716-7720.
12. Yagihashi S, Kamijo M, Watanabe K, (1990) Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats. Am J Pathol 136: 1365-1373.
13. Zhang L, Ino-ue M, Dong K, Yamamoto M, (2000) Retrograde axonal transport impairment of large- and medium-sized retinal ganglion cells in diabetic rat. Curr Eye Res 20: 131-136.
14. Ino-Ue M, Zhang L, Naka H, Kuriyama H, Yamamoto M, (2000) Polyol metabolism of retrograde axonal transport in diabetic rat large optic nerve fiber. Invest Ophthalmol Vis Sci 41: 4055-4058.
15. Fernandez DC, Pasquini LA, Dorfman D, Aldana Marcos HJ, Rosenstein RE, (2012) Early distal axonopathy of the visual pathway in experimental diabetes. Am J Pathol 180: 303-313.
16. Sharma R, Buras E, Terashima T, Serrano F, Massaad CA, et al. (2010) Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice. PLoS One 5: e13463.
17. Andersen CL, Jensen JL, Orntoft TF, (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250.
18. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
19. Hirokawa N, Noda Y, Tanaka Y, Niwa S, (2009) Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol 10: 682-696.
20. Lee JR, Shin H, Ko J, Choi J, Lee H, et al. (2003) Characterization of the movement of the kinesin motor KIF1A in living cultured neurons. J Biol Chem 278: 2624-2629.
21. Chevalier-Larsen E, Holzbaur EL, (2006) Axonal transport and neurodegenerative disease. Biochim Biophys Acta 1762: 1094-1108.
22. McLean WG, (1997) The role of axonal cytoskeleton in diabetic neuropathy. Neurochem Res 22: 951-956.
23. Chung CY, Koprich JB, Siddiqi H, Isacson O, (2009) Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. J Neurosci 29: 3365-3373.
24. Bronk P, Deak F, Wilson MC, Liu X, Sudhof TC, et al. (2007) Differential effects of SNAP-25 deletion on Ca2+-dependent and Ca2+-independent neurotransmission. J Neurophysiol 98: 794-806.
25. Yonekawa Y, Harada A, Okada Y, Funakoshi T, Kanai Y, et al. (1998) Defect in synaptic vesicle precursor transport and neuronal cell death in KIF1A motor protein-deficient mice. J Cell Biol 141: 431-441.
26. Calcutt NA, Tomlinson DR, Willars GB, Keen P, (1990) Axonal transport of substance P-like immunoreactivity in ganglioside-treated diabetic rats. J Neurol Sci 96: 283-291.
27. Abbate SL, Atkinson MB, Breuer AC, (1991) Amount and speed of fast axonal transport in diabetes. Diabetes 40: 111-117.
28. Delcroix JD, Michael GJ, Priestley JV, Tomlinson DR, Fernyhough P, (1998) Effect of nerve growth factor treatment on p75NTR gene expression in lumbar dorsal root ganglia of streptozocin-induced diabetic rats. Diabetes 47: 1779-1785.
29. Hellweg R, Raivich G, Hartung HD, Hock C, Kreutzberg GW, (1994) Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp Neurol 130: 24-30.
30. Lo KY, Kuzmin A, Unger SM, Petersen JD, Silverman MA, (2011) KIF1A is the primary anterograde motor protein required for the axonal transport of dense-core vesicles in cultured hippocampal neurons. Neurosci Lett 491: 168-173.
31. Kondo M, Takei Y, Hirokawa N, (2012) Motor protein KIF1A is essential for hippocampal synaptogenesis and learning enhancement in an enriched environment. Neuron 73: 743-757.
32. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, et al. (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol 143: 777-794.
33. Obulesu M, Venu R, Somashekhar R, (2011) Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology. Neurochem Res 36: 1329-1335.
34. Qu Z, Jiao Z, Sun X, Zhao Y, Ren J, et al. (2011) Effects of streptozotocin-induced diabetes on tau phosphorylation in the rat brain. Brain Res 1383: 300-306.
35. Kim B, Backus C, Oh S, Hayes JM, Feldman EL, (2009) Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 150: 5294-5301.
36. Iqbal K, Liu F, Gong CX, Alonso Adel C, Grundke-Iqbal I, (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118: 53-69.
37. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX, (2011) Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol 225: 54-62.
38. Falzone TL, Stokin GB, Lillo C, Rodrigues EM, Westerman EL, et al. (2009) Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects. J Neurosci 29: 5758-5767.
39. Falzone TL, Gunawardena S, McCleary D, Reis GF, Goldstein LS, (2010) Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies. Hum Mol Genet 19: 4399-4408.
40. Karle KN, Mockel D, Reid E, Schols L, (2012) Axonal transport deficit in a KIF5A(-/-) mouse model. Neurogenetics 13: 169-179.
41. Brownlees J, Ackerley S, Grierson AJ, Jacobsen NJ, Shea K, et al. (2002) Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum Mol Genet 11: 2837-2844.
42. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM, (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156: 1051-1063.
43. Reddy PH, (2011) Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease. Brain Res 1415: 136-148.
44. Fernyhough P, Roy Chowdhury SK, Schmidt RE, (2010) Mitochondrial stress and the pathogenesis of diabetic neuropathy. Expert Rev Endocrinol Metab 5: 39-49.
45. Sima AA, Li ZG, (2005) The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes 54: 1497-1505.
46. Li ZG, Zhang W, Sima AA, (2005) The role of impaired insulin/IGF action in primary diabetic encephalopathy. Brain Res 1037: 12-24.
47. Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, et al. (1998) Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res 800: 125-135.
48. Sima AA, Zhang W, Kreipke CW, Rafols JA, Hoffman WH, (2009) Inflammation in Diabetic Encephalopathy is Prevented by C-Peptide. Rev Diabet Stud 6: 37-42.
49. Kuhad A, Bishnoi M, Tiwari V, Chopra K, (2009) Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacol Biochem Behav 92: 251-259.
50. De Vos K, Goossens V, Boone E, Vercammen D, Vancompernolle K, et al. (1998) The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region. J Biol Chem 273: 9673-9680.
51. De Vos K, Severin F, Van Herreweghe F, Vancompernolle K, Goossens V, et al. (2000) Tumor necrosis factor induces hyperphosphorylation of kinesin light chain and inhibits kinesin-mediated transport of mitochondria. J Cell Biol 149: 1207-1214.
52. Stagi M, Dittrich PS, Frank N, Iliev AI, Schwille P, et al. (2005) Breakdown of axonal synaptic vesicle precursor transport by microglial nitric oxide. J Neurosci 25: 352-362.
53. Stagi M, Gorlovoy P, Larionov S, Takahashi K, Neumann H, (2006) Unloading kinesin transported cargoes from the tubulin track via the inflammatory c-Jun N-terminal kinase pathway. FASEB J 20: 2573-2575.
54. Fang C, Bourdette D, Banker G, (2012) Oxidative stress inhibits axonal transport: implications for neurodegenerative diseases. Mol Neurodegener 7: 29.